Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2014Cancer Immunology ResearchOpen Access

Immune Activation and a 9-Year Ongoing Complete Remission Following CD40 Antibody Therapy and Metastasectomy in a Patient with Metastatic Melanoma

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDavid L. BajorXXXiaowei XuDTDrew A. Torigian

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bajor et al. (2014) studied this question.

synapsesocial.com/papers/6a0cbc2c78bbbfb1e7f2601dhttps://doi.org/10.1158/2326-6066.cir-14-0154
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire2014 · 380 citations
  2. 2CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans2011 · 1,668 citations
  3. 3Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients2014 · 385 citations